Omeros (OMER) EBT Margin Growth (3y) (2013 - 2022)

Omeros (OMER) EBT Margin Growth (3y) (2013 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -484.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 132.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -674,462.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 8,006.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 71,157.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -5,319.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 9,980.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 31,363.00
10 Omeros 1.24 Bn 1.24 Bn 27.73 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2022 -18,378.00
Mar 31, 2022 -46,514.00
Dec 31, 2021 19,721.00
Sep 30, 2021 361,196.00
Jun 30, 2021 630,419.00
Mar 31, 2021 167,803.00
Dec 31, 2020 -67,717.00
Sep 30, 2020 36,443.00
Jun 30, 2020 30,881.00
Mar 31, 2020 45,310.00
Dec 31, 2019 -18,534.00
Sep 30, 2019 28,819.00
Jun 30, 2019 11,697.00
Mar 31, 2019 103,398.00
Dec 31, 2018 23,608.00
Sep 30, 2018 -220,076.00
Jun 30, 2018 -338,372.00
Mar 31, 2018 3.36 Mn
Dec 31, 2017 1.19 Mn
Sep 30, 2017 2.75 Mn